ÂÜÀòÂÒÂ×

Daisy Cross, Ph.D. has a wide range of experience in the fields of biology, biomaterials, and biomedical engineering. Daisy currently serves as a consultant for CoRISMA MCS Systems Inc. and Cryosa Inc., both starting in 2021. From 2012 to 2021, Daisy was a stay at home parent and caregiver/volunteer. From 2008 to 2012, Daisy was a Graduate Research Assistant and Fellow at the University of Minnesota, Biomedical Engineering. In this role, they established strategies to improve cell retention in the heart after cell transplantation to treat myocardial infarction. Daisy also fabricated and characterized degradable polymer microspheres for sustained-release delivery of bioactive molecules for the recruitment of stem cells. From 1999 to 2008, Daisy was a Research Scientist and Intern at Medtronic. In this role, they conducted research in the fields of cell therapy, gene therapy, device-mediated gene delivery, biomaterials, controlled-release of bioactive agents, genetic diagnostics, proteomics, biosensors, protein delivery, drug elution, and hybrid devices. Additionally, they developed and characterized an ionic, physically crosslinked hyaluronic acid biomaterial hydrogel.

Daisy Cross, Ph.D. began their educational journey in 1993 when they earned their B.S. in Biomedical Engineering from Northwestern University. Daisy continued their studies at the University of Minnesota where they earned an M.S. in Environmental Toxicology in 1999. Finally, in 2007 they completed their Ph.D. in Biomedical Engineering from the University of Minnesota.